The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Affiliation
Instituto Português de Oncologia de Lisboa FG
Country
Portugal
Current Status, Position
Dr Antonio Gouveia is currently Chief Pharmacist at Instituto Português de Oncologia de Lisboa FG. He is also Vice-President of the National Health Technology Assessment Committee in the Portuguese regulatory agency, Infarmed.
Education
Dr Antonio Gouveia studied pharmacy at the University of Lisbon. He has attended several post-graduate courses in regulatory affairs and management.
Research Area
Dr Antonio Gouveia’s research focuses on hospital pharmacy practice, with a focus on oncology and governance.
Conflict of interest: none